Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Sep;64(9):1249–1251. doi: 10.1136/ard.2005.039339

Great expectations of modern RA treatment

S Irvine 1, H Capell 1
PMCID: PMC1755639  PMID: 16100338

Full Text

The Full Text of this article is available as a PDF (56.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dougados Maxime, Emery Paul, Lemmel Ernst-Martin, de la Serna Rodriguez, Zerbini Cristiano A., Brin Sylvie, van Riel Piet. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data. J Rheumatol. 2003 Dec;30(12):2572–2579. [PubMed] [Google Scholar]
  2. Fransen J., Moens H. Bernelot, Speyer I., van Riel P. L. C. M. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis. 2005 Apr 13;64(9):1294–1298. doi: 10.1136/ard.2004.030924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fries J. F., Williams C. A., Morfeld D., Singh G., Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum. 1996 Apr;39(4):616–622. doi: 10.1002/art.1780390412. [DOI] [PubMed] [Google Scholar]
  4. Grigor Catriona, Capell Hilary, Stirling Anne, McMahon Alex D., Lock Peter, Vallance Ramsay, Kincaid Wilma, Porter Duncan. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004 Jul 17;364(9430):263–269. doi: 10.1016/S0140-6736(04)16676-2. [DOI] [PubMed] [Google Scholar]
  5. Klareskog Lars, van der Heijde Désirée, de Jager Julien P., Gough Andrew, Kalden Joachim, Malaise Michel, Martín Mola Emilio, Pavelka Karel, Sany Jacques, Settas Lucas. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet. 2004 Feb 28;363(9410):675–681. doi: 10.1016/S0140-6736(04)15640-7. [DOI] [PubMed] [Google Scholar]
  6. Leeb B. F., Andel I., Leder S., Leeb B. A., Rintelen B. The patient's perspective and rheumatoid arthritis disease activity indexes. Rheumatology (Oxford) 2004 Nov 30;44(3):360–365. doi: 10.1093/rheumatology/keh484. [DOI] [PubMed] [Google Scholar]
  7. Leeb B. F., Andel I., Sautner J., Nothnagl T., Rintelen B. The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology (Oxford) 2004 Jul 13;43(12):1504–1507. doi: 10.1093/rheumatology/keh322. [DOI] [PubMed] [Google Scholar]
  8. Möttönen T., Hannonen P., Leirisalo-Repo M., Nissilä M., Kautiainen H., Korpela M., Laasonen L., Julkunen H., Luukkainen R., Vuori K. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet. 1999 May 8;353(9164):1568–1573. doi: 10.1016/s0140-6736(98)08513-4. [DOI] [PubMed] [Google Scholar]
  9. Nicolau Giuliana, Yogui Melissa M., Vallochi Tatiana L., Gianini Reinaldo J., Laurindo Ieda M. M., Novaes Gilberto S. Sources of discrepancy in patient and physician global assessments of rheumatoid arthritis disease activity. J Rheumatol. 2004 Jul;31(7):1293–1296. [PubMed] [Google Scholar]
  10. O'Dell J. R., Haire C. E., Erikson N., Drymalski W., Palmer W., Eckhoff P. J., Garwood V., Maloley P., Klassen L. W., Wees S. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med. 1996 May 16;334(20):1287–1291. doi: 10.1056/NEJM199605163342002. [DOI] [PubMed] [Google Scholar]
  11. O'Dell James R., Leff Robert, Paulsen Gail, Haire Claire, Mallek Jack, Eckhoff P. James, Fernandez Ana, Blakely Kent, Wees Steven, Stoner Julie. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002 May;46(5):1164–1170. doi: 10.1002/art.10228. [DOI] [PubMed] [Google Scholar]
  12. Plant M. J., Williams A. L., O'Sullivan M. M., Lewis P. A., Coles E. C., Jessop J. D. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2000 Jul;43(7):1473–1477. doi: 10.1002/1529-0131(200007)43:7<1473::AID-ANR9>3.0.CO;2-N. [DOI] [PubMed] [Google Scholar]
  13. Prevoo M. L., van Gestel A. M., van T Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996 Nov;35(11):1101–1105. doi: 10.1093/rheumatology/35.11.1101. [DOI] [PubMed] [Google Scholar]
  14. Scheel Alexander K., Hermann Kay-Geert A., Kahler Elke, Pasewaldt Daniel, Fritz Jacqueline, Hamm Bernd, Brunner Edgar, Müller Gerhard A., Burmester Gerd R., Backhaus Marina. A novel ultrasonographic synovitis scoring system suitable for analyzing finger joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2005 Mar;52(3):733–743. doi: 10.1002/art.20939. [DOI] [PubMed] [Google Scholar]
  15. Svensson B., Schaufelberger C., Teleman A., Theander J. Remission and response to early treatment of RA assessed by the Disease Activity Score. BARFOT study group. Better Anti-rheumatic Farmacotherapy. Rheumatology (Oxford) 2000 Sep;39(9):1031–1036. doi: 10.1093/rheumatology/39.9.1031. [DOI] [PubMed] [Google Scholar]
  16. Uitz E., Fransen J., Langenegger T., Stucki G. Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss Clinical Quality Management in Rheumatoid Arthritis. Rheumatology (Oxford) 2000 May;39(5):542–549. doi: 10.1093/rheumatology/39.5.542. [DOI] [PubMed] [Google Scholar]
  17. Welsing Paco M. J., Landewé Robert B. M., van Riel Piet L. C. M., Boers Maarten, van Gestel Anke M., van der Linden Sjef, Swinkels Hilde L., van der Heijde Désirée M. F. M. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum. 2004 Jul;50(7):2082–2093. doi: 10.1002/art.20350. [DOI] [PubMed] [Google Scholar]
  18. van Gestel A. M., Haagsma C. J., van Riel P. L. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum. 1998 Oct;41(10):1845–1850. doi: 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  19. van Gestel A. M., Prevoo M. L., van 't Hof M. A., van Rijswijk M. H., van de Putte L. B., van Riel P. L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996 Jan;39(1):34–40. doi: 10.1002/art.1780390105. [DOI] [PubMed] [Google Scholar]
  20. van Leeuwen M. A., van Rijswijk M. H., van der Heijde D. M., Te Meerman G. J., van Riel P. L., Houtman P. M., van De Putte L. B., Limburg P. C. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol. 1993 Jun;32 (Suppl 3):9–13. doi: 10.1093/rheumatology/32.suppl_3.9. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES